View Older Stories View More Recent Stories

May 29, 2026 12:07PM Morgan Stanley: China healthcare sector dips 1.3% amid licensing scrutiny
May 29, 2026 08:02AM Pfizer's LORBRENA shows 55% seven-year survival without progression
May 27, 2026 09:46AM UBS Reiterates Neutral Rating on Pfizer (PFE)
May 13, 2026 02:53PM Arvinas Inc. (ARVN) PT Raised to $16 at BofA Securities
May 13, 2026 06:45AM European Commission approves Pfizer's HYMPAVZI for hemophilia with inhibitors
May 12, 2026 12:53PM FDA Commissioner Marty Makary to step down - Politico
May 12, 2026 07:01AM Arvinas and Pfizer sell VEPPANU rights to Rigel for $85 million upfront
May 12, 2026 05:37AM MBX Biosciences (MBX) PT Raised to $86 at Citizens on 'Good' MBX 4291 Update
May 11, 2026 10:23AM HHS downplays Hantavirus risk amid repatriation efforts
May 8, 2026 12:04PM Health officials explore restrictions on certain SSRI antidepressants - Reuters
May 7, 2026 02:15PM Novo Nordisk Eyes Large-Scale M&A Following Pfizer's Metsera Win - Semafor
May 5, 2026 03:11PM Pfizer (PFE) PT Raised to $27 at BofA Securities
May 5, 2026 02:11PM Pfizer Reviewing New Molecule It Designed Using AI - CEO
May 5, 2026 07:17AM Pfizer beats first quarter estimates on strong product growth
May 5, 2026 06:46AM Pfizer (PFE) Tops Q1 EPS by 3c, Beats on Revenue; Offers FY26 EPS Guidance
May 4, 2026 11:18AM Pfizer (PFE) call put ratio 4.7 calls to 1 put quarter results
May 4, 2026 05:38AM Pfizer (PFE) calls more active than puts into quarter results
May 1, 2026 10:50AM Pfizer (PFE) call put ratio 2.9 calls to 1 put with a focus on May 8 weekly 27 calls into quarter results
Apr 29, 2026 06:45AM Pfizer's ELREXFIO meets primary endpoint in multiple myeloma trial
Apr 28, 2026 02:00PM Raymond James on BridgeBio Pharma (BBIO): 'We expect continued strong commercial momentum for Attruby'
Apr 28, 2026 12:14PM Barclays on BridgeBio Pharma (BBIO): 'We see buying opportunity on weakness, reiterate top idea'
Apr 28, 2026 11:46AM TD Cowen on BridgeBio Pharma (BBIO): 'A key overhang is removed now'
Apr 28, 2026 11:41AM RBC Capital on BridgeBio Pharma (BBIO): 'we remain buyers'
Apr 28, 2026 11:25AM Mizuho on BridgeBio Pharma (BBIO): 'Not Best Case but Still Good Outcome Relative to Street'
Apr 28, 2026 10:53AM Morgan Stanley on Pfizer (PFE): 'we believe generic versions of Vyndaqel could still represent a potential headwind to the franchise'
Apr 28, 2026 10:17AM Pfizer extends VYNDAMAX patent protection to 2031 through settlements
Apr 28, 2026 09:48AM Mizuho: 'BBIO could potentially trade in the $90-110+ range today / near-term'
Apr 28, 2026 09:46AM RBC on Pfizer (PFE): 'Litigation overhang cleared'
Apr 28, 2026 09:38AM Barclays: 'We think dropping the question of '441 validity from the case is a major development'
Apr 24, 2026 06:59AM Bristol Myers Squibb and Pfizer partner with Mark Cuban's Cost Plus Drugs
Apr 15, 2026 06:14AM CICC Starts Pfizer (PFE) at Outperform
Apr 13, 2026 09:51AM Pfizer (PFE) PT Raised to $27 at UBS
Apr 13, 2026 06:58AM Guggenheim Reiterates Buy Rating on Pfizer (PFE)
Apr 9, 2026 09:24AM Pfizer (PFE) PT Lowered to $26 at BofA Securities
Apr 7, 2026 08:54AM RBC Capital Reiterates Underperform Rating on Pfizer (PFE)
Apr 1, 2026 03:01PM Leerink Partners on Pfizer (PFE): 'positive ruling today should drive additional Comirnaty OUS sales'
Mar 31, 2026 01:10PM Pfizer (PFE) to shutter South S.F. research site, end Bay Area presence - Bloomberg
Mar 31, 2026 06:35AM Wolfe: 'We're observing some reports of GLP-1 users refreshing their wardrobes as weight loss progresses'
Mar 24, 2026 06:31AM Pfizer (PFE) PT Raised to $36 at Guggenheim
Mar 20, 2026 04:30PM Pfizer advises shareholders to reject Tutanota mini-tender offer
Mar 19, 2026 06:45AM Pfizer's TALZENNA combination shows progress against prostate cancer
Mar 17, 2026 08:39AM Morgan Stanley on Pfizer (PFE): Atirmo Ph2 data an 'incremental positive'
Mar 17, 2026 05:42AM Stocks expected to have increasing option volume: LMND MRNA PFE BNTX NVAX AZN BMY LLY GSK JNJ MRK NVS MRK SNY
Mar 16, 2026 03:46PM US Judge blocks Trump Admin cuts to number of routinely recommended vaccines for children - Reuters
Mar 9, 2026 11:51AM BMO Capital Reiterates Outperform Rating on Pfizer (PFE) following Ph2 data
Mar 9, 2026 10:53AM FDA: 'The agency today is withdrawing final guidance titled “Scientific Considerations in Demonstrating Biosimilarity to a Reference Product'
Mar 2, 2026 07:34AM Argus Upgrades Pfizer (PFE) to Buy
Feb 27, 2026 10:04AM PADCEV plus Keytruda reduces bladder cancer recurrence risk by 47%
Feb 24, 2026 04:05PM RBC Capital Starts Pfizer (PFE) at Underperform
Feb 24, 2026 02:30PM FDA approves Pfizer's BRAFTOVI for colorectal cancer treatment
View More Recent Stories View Older Stories